Latest / The Jill Bennett Show
Why was a woman's coverage for a cancer drug denied?
A woman's public coverage for cancer drug Keytruda was denied, largely, it seems, on the basis that too few cancer patients have survived long enough to justify coverage beyond two years. Guest: Richard Zussman - Global News Legislative Reporter Learn more about your ad choices. Visit megaphone.fm/adchoices
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.